ATE361056T1 - Lippenbehandlungsmittel enthaltend ein derivat von hefezellen - Google Patents

Lippenbehandlungsmittel enthaltend ein derivat von hefezellen

Info

Publication number
ATE361056T1
ATE361056T1 AT97938195T AT97938195T ATE361056T1 AT E361056 T1 ATE361056 T1 AT E361056T1 AT 97938195 T AT97938195 T AT 97938195T AT 97938195 T AT97938195 T AT 97938195T AT E361056 T1 ATE361056 T1 AT E361056T1
Authority
AT
Austria
Prior art keywords
derivative
lip treatment
lips
yeast cells
products containing
Prior art date
Application number
AT97938195T
Other languages
English (en)
Inventor
Neil Scancarella
Harold Pahlck
Maha Raouf
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Application granted granted Critical
Publication of ATE361056T1 publication Critical patent/ATE361056T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/001—Preparations for care of the lips

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97938195T 1996-08-30 1997-08-07 Lippenbehandlungsmittel enthaltend ein derivat von hefezellen ATE361056T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/705,779 US5776441A (en) 1996-08-30 1996-08-30 Lip treatment containing live yeast cell derivative

Publications (1)

Publication Number Publication Date
ATE361056T1 true ATE361056T1 (de) 2007-05-15

Family

ID=24834911

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97938195T ATE361056T1 (de) 1996-08-30 1997-08-07 Lippenbehandlungsmittel enthaltend ein derivat von hefezellen

Country Status (9)

Country Link
US (1) US5776441A (de)
EP (1) EP0957888B1 (de)
JP (2) JP2000516951A (de)
AT (1) ATE361056T1 (de)
AU (1) AU4057897A (de)
BR (1) BR9711245A (de)
CA (1) CA2264877C (de)
DE (1) DE69737693T2 (de)
WO (1) WO1998008484A1 (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN187860B (de) * 1997-08-27 2002-07-06 Revlon Consumer Prod Corp
WO1999009936A1 (en) * 1997-08-27 1999-03-04 Revlon Consumer Products Corporation Method for treating chapped lips
US5882666A (en) * 1997-11-20 1999-03-16 Averill; Robert G. Skin care compounds and preparation thereof
DE19802444A1 (de) * 1998-01-23 1999-07-29 Beiersdorf Ag Haarkosmetische Zubereitungen enthaltend Sonnenblumenwachs und gewünschtenfalls Jojobawachs
US6177105B1 (en) 1998-02-20 2001-01-23 Steven K. Grekin LYCD compositions and therapy
US6809075B1 (en) 2000-05-30 2004-10-26 Connective Tissue Imagineering Llc Elastin peptide analogs and uses of same incombination with skin enhancing agents
US6962904B1 (en) 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6777389B1 (en) 1998-11-19 2004-08-17 Connective Tissue Imagineering Llc Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
DE19940221C1 (de) 1999-08-19 2001-05-23 Coty Bv Körperpflegemittel in Form eines frei stehenden Stiftes
US6794362B1 (en) * 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
US6461857B1 (en) * 2000-07-19 2002-10-08 Arch Personal Care Products, L.P. Producing water-soluble yeast extract by adding peroxide to growing yeast cells
US6855345B2 (en) * 2001-11-02 2005-02-15 Morinda, Inc. Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
US7048952B2 (en) * 2002-05-21 2006-05-23 Morinda, Inc. Formulation for inhibiting fungal and microbial growth comprising morinda citrifolia puree juice
US8652546B2 (en) 2007-09-06 2014-02-18 Tahitian Noni International, Inc. Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
US20110171333A1 (en) * 2000-12-05 2011-07-14 Bryant Wadsworth Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products
US20110217394A1 (en) * 2000-12-05 2011-09-08 Brett Justin West Iridoid Based Formulations
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US20120237626A9 (en) * 2000-12-05 2012-09-20 Palu Afa Kehaati Profiles of lipid proteins and inhibiting HMG-CoA reductase
US8574642B2 (en) 2000-12-05 2013-11-05 Tahitian Noni International, Inc. Antiviral Morinda citrifolia L. based formulations and methods of administration
US7244463B2 (en) * 2005-10-18 2007-07-17 Tahitian Noni International, Inc. Garcinia mangostana L. enhanced animal food product
US20070196527A1 (en) * 2006-02-23 2007-08-23 Jensen Claude J Preventative and treatment effects of Morinda citrifolia on Osteoarthritis and its related conditions
US20040192761A1 (en) * 2003-03-25 2004-09-30 Palu Afa Kehaati Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor
EP1389124A4 (de) * 2001-04-17 2004-12-15 Morinda Inc Palliative wirkungen von öl und saft von morinda citrifolia
US7070813B2 (en) * 2001-11-02 2006-07-04 Morinda, Inc. Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor
US20110160057A1 (en) * 2001-11-14 2011-06-30 Bryant Wadsworth Morinda Citrifolia Based Antimicrobial Formulations
US7442395B2 (en) * 2002-11-14 2008-10-28 Tahitian Noni International, Inc. Formulation for treating candidiasis using Morinda citrifolia
US20030198682A1 (en) * 2002-02-12 2003-10-23 Gruber James V. Composition and method for protecting labile active components during high temperature drying
US6723307B2 (en) * 2002-02-14 2004-04-20 Bonne Bell, Inc. Cosmetic lip product with sour flavor
US20030161851A1 (en) * 2002-02-14 2003-08-28 Bonne Bell, Inc. Cosmetic lip product with sour flavor
US6706768B2 (en) * 2002-03-21 2004-03-16 International Flora Technologies, Ltd. Production and use of novel alkoxylated monoesters
DE10243437A1 (de) * 2002-09-18 2004-04-29 Pm-International Ag Kosmetische Formulierung
FR2851914B1 (fr) * 2003-03-06 2005-06-03 Oreal Composition cosmetique brillante
US20060269630A1 (en) * 2003-04-16 2006-11-30 Palu Afa K Morinda citrifolia as a 5-Lipoxygenase inhibitor
US20050106275A1 (en) * 2003-05-02 2005-05-19 Chen Su Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells
JP4073826B2 (ja) * 2003-06-04 2008-04-09 タヒチアン ノニ インターナショナル インコーポレーテッド ヤエヤマアオキの抽出物を含む農業用活力剤
US20070259060A1 (en) * 2003-08-12 2007-11-08 Mian-Ying Wang Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane
US7416756B2 (en) * 2003-09-10 2008-08-26 Eastman Chemical Company Process for the recovery of a phytolipid composition
US20050260291A1 (en) * 2004-03-10 2005-11-24 Palu Afa K Methods and compositions for reactivating acetylcholinesterase
WO2006028826A2 (en) * 2004-09-01 2006-03-16 Paulus Wang Morinda citrifolia-based formulations and methods for weight management
US20060110815A1 (en) 2004-10-13 2006-05-25 Gruber James V Personal care composition containing ozone-stressed yeast lysates
US20060141076A1 (en) * 2004-11-01 2006-06-29 Palu Afa K Morinda citrifolia based compositions and methods for inhibiting xanthine oxidase
US20060204601A1 (en) * 2005-03-09 2006-09-14 Palu Afa K Formulations and methods for preventing and treating substance abuse and addiction
FR2885491B1 (fr) * 2005-05-16 2020-03-06 Nutricos Technologies Traitement de la secheresse keratinique par des glycerides
US20060280818A1 (en) * 2005-05-26 2006-12-14 Palu Afa K Nicotinic acetylcholine receptor antagonist
US20070122507A1 (en) * 2005-05-26 2007-05-31 Palu Afa K Histone deacetylase and tumor necrosis factor converting enzyme inhibition
US20070154579A1 (en) * 2005-11-29 2007-07-05 Palu Afa K Morinda Citrifolia Based Formulation And Methods For Weight Management
US20070237848A1 (en) * 2005-12-21 2007-10-11 Brad Rawson MORINDA CITRIFOLIA BASED COMPOSITIONS FOR TREATMENT OF ANTI-INFLAMMATORY DISEASES THROUGH INHIBITION OF COX-1, COX-2, INTERLEUKIN-1beta, INTERLEUKIN-6, TNF-alpha, HLE, AND iNOS
WO2007084972A1 (en) * 2006-01-20 2007-07-26 Elc Management Llc Topical preparations comprising flower wax and candelilla
US20100008880A1 (en) * 2006-05-03 2010-01-14 John Castro Clear Cosmetic Compositions And Methods Of Using
US20070259012A1 (en) * 2006-05-03 2007-11-08 John Castro Clear Cosmetic Compositions and Methods Of Use
US20070281903A1 (en) * 2006-05-04 2007-12-06 Palu Afa K Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX
US8025910B2 (en) 2006-05-12 2011-09-27 Tahitian Noni International, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US8535741B2 (en) 2006-05-12 2013-09-17 Morinda, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US20080226758A1 (en) * 2006-11-28 2008-09-18 Shixin Deng Lipoxygenase and Cyclooxygenase Inhibition
US20080213415A1 (en) * 2007-02-08 2008-09-04 Palu Afa K Treatment of Glaucoma and Diabetic Retinopathy with Morinda Citrifolia Enhanced Formulations
US20080317890A1 (en) * 2007-06-21 2008-12-25 Claude Jarakae Jensen Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical
US20090196944A1 (en) * 2008-02-01 2009-08-06 Brad Rawson Methods of Manufacture of Morinda Citrifolia Based Compositions for Treatment of Anti-Inflammatory Diseases through Inhibition of Cox-1, Cox-2, Interleukin -1beta, Interleukin-6, TNF-alpha, HLE, and iNOS
CN102014855A (zh) * 2008-05-09 2011-04-13 乐敦制药株式会社 棒状化妆材料、棒状化妆品及它们的制造方法
EP2371877B1 (de) 2008-11-28 2026-04-29 Mitsubishi Chemical Corporation Polycarbonatharz, polycarbonatharzzusammensetzung, optische folie und polycarbonatharzformkörper
MX2012001374A (es) * 2009-08-31 2012-03-06 Avon Prod Inc Usos cosmeticos de extractos de levadura estresada modificados y composiciones relacionadas.
US20110206786A1 (en) * 2010-02-23 2011-08-25 Brett Justin West Acai and Iridoid Based Formulations
US9044621B2 (en) 2011-05-13 2015-06-02 Mary Kay Inc. Lip stick
US9051535B2 (en) 2012-03-26 2015-06-09 Advanced Biocatalytics Corporation Protein-enhanced surfactants for enzyme activation
JP6077216B2 (ja) * 2012-03-26 2017-02-08 株式会社 資生堂 油性化粧料
JP6245850B2 (ja) * 2012-06-01 2017-12-13 ロート製薬株式会社 外用組成物
US9023327B2 (en) 2012-08-30 2015-05-05 Avon Products, Inc. DICKKOPF-1 expression modulating compositions and uses thereof
WO2018175334A1 (en) 2017-03-20 2018-09-27 Es Biosolutions, Inc. Compositions and methods for skin treatments

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2320478A (en) * 1939-06-19 1943-06-01 Inst Divi Thomae Foundation Toilet preparation
US2320479A (en) * 1939-06-19 1943-06-01 Inst Divi Thomae Foundation Topical remedy
US5023090A (en) * 1989-08-16 1991-06-11 Levin Robert H Topical compositions containing LYCD and other topically active medicinal ingredients for the treatment of ACNE
US4873078A (en) * 1988-04-22 1989-10-10 Plough, Inc. High-gloss, high-shine lipstick
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
US5204105A (en) * 1990-04-10 1993-04-20 Chanel, Inc. Cosmetic composition
JPH0570326A (ja) * 1991-05-30 1993-03-23 Pola Chem Ind Inc リツプ化粧料
GB9114255D0 (en) * 1991-07-02 1991-08-21 Unilever Plc Cosmetic composition
DE4306068A1 (de) * 1993-03-01 1994-09-15 Beiersdorf Ag Kosmetische Stifte
KR0118776B1 (ko) * 1994-03-04 1997-10-17 한동근 파피아 효모 분체를 함유하는 색조 화장료 조성물
US5643587A (en) * 1996-02-15 1997-07-01 Avon Products, Inc. Composition and method for under-eye skin lightening

Also Published As

Publication number Publication date
EP0957888A1 (de) 1999-11-24
US5776441A (en) 1998-07-07
EP0957888B1 (de) 2007-05-02
JP2000516951A (ja) 2000-12-19
EP0957888A4 (de) 2001-08-22
JP2009143952A (ja) 2009-07-02
AU4057897A (en) 1998-03-19
CA2264877C (en) 2003-12-30
CA2264877A1 (en) 1998-03-05
BR9711245A (pt) 1999-08-17
DE69737693D1 (de) 2007-06-14
WO1998008484A1 (en) 1998-03-05
DE69737693T2 (de) 2008-01-10

Similar Documents

Publication Publication Date Title
ATE361056T1 (de) Lippenbehandlungsmittel enthaltend ein derivat von hefezellen
ATE5371T1 (de) Kosmetische mittel.
ATE141785T1 (de) Zusammensetzung und methode zur verstärkung der sonnenbräunung
DK0970701T3 (da) Pellets afledt fra keratinocytter til anvendelse som sårhelingsstoffer
ES2100560T3 (es) Formulaciones cosmeticas y dermatologicas de proteccion solar que contienen tioles y/o derivados de tiol.
GEP20022638B (en) Inhibitors of Interleukin- 1β Converting Enzyme
ES2161760T3 (es) Composiciones de proteccion solar que contienen extractos de avena.
DE69630955D1 (de) Immortalisierung bzw. desimmortalisierung von zellen
GB2301363A (en) Human phosphodiesterase type ivc and its production and use
PT1017659E (pt) Tetra-hidronaftalenos substituidos e compostos analogos
DK528886D0 (da) Fremgangsmaade og anlaeg til nedbrydning af organiske materialer, biprodukter og affaldsstoffer af human, animalsk og/eller vegetabilsk oprindelse i anaerobt miljae
SE8302654D0 (sv) A method for producing ethanol from xylose-containing substance
ATE377022T1 (de) Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung
NO981072D0 (no) Neural transplantasjon ved anvendelse av pluripotente neuroepitelceller
DK490486A (da) Sammensaetning til behandling af atherosclerose, tromboser og/eller perifere karsygdomme
ATE125549T1 (de) Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel.
TR199801039T2 (xx) Yeni fenilamidin t�revlerinin elde edilmesine y�nelik usul.
DE69624370D1 (de) Verfarhen zur herstellung von glycogen oder glycogenreichem hefeextrakt aus hefezellen und kosmetische zusammensetzungen, die diese enthalten
BR9408023A (pt) Formulações de fenbendazol
ATE98130T1 (de) Kombination von angiotensin-converting-enzymehemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln.
ATE168988T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
ATE302264T1 (de) Freigabe von intrazellulärem material
FR2693906B1 (fr) Extraits bruts d'algues bleues, leurs procédés de préparation et leurs applications en cosmétologie et en dermatologie.
DE69725100D1 (de) Verfahren und Satz zur Prüfung der Drogenempfindlichkeit von Mikroben, sowie Verfahren und Satz zur Missung der minimumhemmenden Konzentration von Mikroorganismen
SE8107468L (sv) Komposition for behandling av psoriasis pa basis av en 1,8-dihydroxi-9-antron substituerad i 10-stellningen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties